Mohammad E. Allaf
Elite in Renal Oncocytoma

Dr. Mohammad E. Allaf

Oncology | Urology
Johns Hopkins Medicine
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
10803 Falls Road, Pavilion III STE 3300, Pavilion III STE 3300, 
Lutherville, MD 

Elite in Renal Oncocytoma
Johns Hopkins Medicine
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
10803 Falls Road, Pavilion III STE 3300, Pavilion III STE 3300, 
Lutherville, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dr. Mohamad Allaf is Professor of Urology and Oncology, as well as Director of the Department of Urology and the Brady Urological Institute and Urologist-in-Chief of the Johns Hopkins Hospital. Dr. Allaf is a world renowned surgeon-scientist having performed more than 2,000 robotic procedures and published over 250 peer reviewed research papers in the field's best journals. As one of the busiest robotic radical prostatectomy surgeons in the world, he aims to achieve the best outcomes for his patients. Having trained with Dr. Patrick Walsh, Dr. Allaf has used Dr. Walsh's method of radical prostatectomy as the basis for his own anatomic method to this complex operation. Dr. Allaf is also amongst the leaders in kidney cancer surgery, having served on the American Urological Association Guideline Committee for Kidney Cancer. He led a team who performed the rigorous analysis to help inform the most recent guidelines that was funded by the Agency for Healthcare Research and Quality (AHRQ). He is best known for his ability to save the kidney and remove the tumor in patients with kidney tumors. Dr. Allaf runs a research endeavor aiming to decrease the morbidity associated with the treatment of cancer, and he has mentored numerous leaders in academic urology. He is actively involved in fund raising for research and education, and believes in expanding our base of support in order to advance our important mission.

Dr. Allaf is rated as an Elite provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Renal Oncocytoma, Prostate Cancer, Nephrectomy, and Prostatectomy.

His clinical research consists of co-authoring 259 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 15 articles and participated in 1 clinical trial in the study of Renal Oncocytoma.

Residency
Johns Hopkins University School of Medicine, Urology, 2006
Specialties
Oncology
Urology
Licenses
Urology in MD
Board Certifications
American Board Of Urology
Hospital Affiliations
Sibley Memorial Hospital
The Johns Hopkins Hospital
Johns Hopkins Bayview Medical Center
Languages Spoken
English
Arabic
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
10803 Falls Road, Pavilion III STE 3300, Pavilion III STE 3300, Lutherville, MD 21093
Call: 410-955-6100

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


10 Clinical Trials

A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
Enrollment Status: Active_not_recruiting
Publish Date: December 02, 2025
Intervention Type: Other, Biological, Procedure
Study Drug: Nivolumab
Study Phase: Phase 3
Evaluation of Transperineal Biopsy Under Local Anesthesia, a Novel Approach to Decrease Post-Biopsy Infections and Improve Cancer Detection
Evaluation of Transperineal Biopsy Under Local Anesthesia, a Novel Approach to Decrease Post-Biopsy Infections and Improve Cancer Detection
Enrollment Status: Completed
Publish Date: April 15, 2025
Intervention Type: Procedure, Drug
Study Phase: Not Applicable
A Confirmatory, Prospective, Open-label, Multi-centre Phase 3 Study to Evaluate Diagnostic Performance of Zirconium-labelled Girentuximab to Non-invasively Detect ccRCC by PET/CT Imaging in Patients With Indeterminate Renal Masses
A Confirmatory, Prospective, Open-label, Multi-centre Phase 3 Study to Evaluate Diagnostic Performance of Zirconium-labelled Girentuximab to Non-invasively Detect ccRCC by PET/CT Imaging in Patients With Indeterminate Renal Masses
Enrollment Status: Completed
Publish Date: May 17, 2024
Intervention Type: Diagnostic test
Study Phase: Phase 3
Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy: a Prospective Randomized Controlled Trial (ERECT)
Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy: a Prospective Randomized Controlled Trial (ERECT)
Enrollment Status: Completed
Publish Date: April 08, 2021
Intervention Type: Drug
Study Phase: Phase 2
Augmented BLAdder NecK rEconstruction Trial for Improved Urinary Function After Radical Prostatectomy
Augmented BLAdder NecK rEconstruction Trial for Improved Urinary Function After Radical Prostatectomy
Enrollment Status: Terminated
Publish Date: March 17, 2021
Intervention Type: Procedure
Study Phase: Not Applicable
A Randomized Controlled Trial for PREvention of VENous ThromboEmbolism Following Radical Prostatectomy (PREVENTER Trial)
A Randomized Controlled Trial for PREvention of VENous ThromboEmbolism Following Radical Prostatectomy (PREVENTER Trial)
Enrollment Status: Terminated
Publish Date: August 05, 2020
Intervention Type: Drug
Study Phase: Phase 4
Phase I Study of Neoadjuvant Nivolumab in Patients With Non-metastatic High-risk Clear Cell Renal Cell Carcinoma
Phase I Study of Neoadjuvant Nivolumab in Patients With Non-metastatic High-risk Clear Cell Renal Cell Carcinoma
Enrollment Status: Completed
Publish Date: June 12, 2020
Intervention Type: Drug
Study Phase: Phase 1
Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma
Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma
Enrollment Status: Completed
Publish Date: April 29, 2020
Intervention Type: Drug, Procedure
Study Phase: Not Applicable
Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma
Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma
Enrollment Status: Completed
Publish Date: July 30, 2019
Intervention Type: Other
Study Phase: Not Applicable
A Phase 3 Study to Evaluate the Safety and Efficacy of 99mTc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men With Biopsy Proven Low-Grade Prostate Cancer Who Are Candidates for Active Surveillance (proSPECT-AS)
A Phase 3 Study to Evaluate the Safety and Efficacy of 99mTc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men With Biopsy Proven Low-Grade Prostate Cancer Who Are Candidates for Active Surveillance (proSPECT-AS)
Enrollment Status: Completed
Publish Date: April 10, 2019
Intervention Type: Drug, Diagnostic test
Study Phase: Phase 3
View 9 Less Clinical Trials

259 Total Publications

Clinically significant prostate cancer detected by systematic biopsy in patients with MRI lesions.
Clinically significant prostate cancer detected by systematic biopsy in patients with MRI lesions.
Journal: BJU international
Published: June 12, 2025
View All 259 Publications
Similar Doctors
Elite in Renal Oncocytoma
Dr. Mark W. Ball
Urology | Plastic Surgery
Elite in Renal Oncocytoma
Dr. Mark W. Ball
Urology | Plastic Surgery
10 Center Drive Rm 2-5942, 
Bethesda, MD 
 (34.8 miles away)
240-858-3700
Languages Spoken:
English
See accepted insurances

Mark Ball is a Plastic Surgeon and an Urologist in Bethesda, Maryland. Dr. Ball is rated as a Distinguished provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Von Hippel-Lindau (VHL) Syndrome, Renal Cell Carcinoma (RCC), Renal Oncocytoma, Nephrectomy, and Prostatectomy.

Thomas W. Jarrett
Advanced in Renal Oncocytoma
Dr. Thomas W. Jarrett
Urology
Advanced in Renal Oncocytoma
Dr. Thomas W. Jarrett
Urology

Sibley Memorial Hospital

5215 Loughboro Road Northwest, Suite 150, Suite 150, 
Washington, DC 
 (36.4 miles away)
202-660-5561
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Dr. Thomas W. Jarrett has an expertise in minimally invasive surgery, including laparoscopic, robotic, ureteroscopic, percutaneous and image-guided therapies. Specifically, he has an expertise in percutaneous renal surgery, laparoscopic partial and radical nephrectomy, kidney stones, urinary tract reconstruction and kidney cancer. Dr. Jarrett earned his medical degree from Emory University School of Medicine, where he also completed his internship. He completed a residency in urology at New York Hospital, followed by a visiting fellowship in urology and ultrasonography in Salzburg, Austria. Dr. Jarrett completed his fellowship in endo-urology at Long Island Jewish Medical Center. He has previously served as the chief of the division of endourology and laparoscopy at the Johns Hopkins Hospital and the chief of the division of urology at Johns Hopkins Bayview Medical Center. Dr. Jarrett has been named a Top MD by Consumers’ Checkbook Magazine and a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly. He has also been named a Super Doctor by the Washington Post. Dr. Jarrett is a member of the American Urological Association, the Society of Urologic Oncology and the Endourological Society. Dr. Jarrett has contributed to various publications and presentations on urology, earning him first prize in the World Congress of Endourology essay contest and the Faculty Research Award at Long Island Jewish Medical Center. He has editorial appointments at the Journal of Endourology and the Journal of Laparoendoscopic and Advanced Surgical Techniques. Dr. Jarrett is rated as a Distinguished provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Ureterocele, Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Nephrectomy, and Ureteroscopy.

Advanced in Renal Oncocytoma
Dr. Eric J. Schwartz
Urology
Advanced in Renal Oncocytoma
Dr. Eric J. Schwartz
Urology

Anne Arundel Urology, PA

600 Ridgely Ave, Suite 130, 
Annapolis, MD 
 (21.2 miles away)
410-266-8049
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Eric Schwartz is an Urologist in Annapolis, Maryland. Dr. Schwartz is rated as a Distinguished provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Ureteroscopy, and Prostatectomy. Dr. Schwartz is currently accepting new patients.

VIEW MORE RENAL ONCOCYTOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Allaf's expertise for a condition
ConditionClose
  • Elite
  • Nephrectomy
    Dr. Allaf is
    Elite
    . Learn about Nephrectomy.
    See more Nephrectomy experts
  • Prostate Cancer
    Dr. Allaf is
    Elite
    . Learn about Prostate Cancer.
    See more Prostate Cancer experts
  • Prostatectomy
    Dr. Allaf is
    Elite
    . Learn about Prostatectomy.
    See more Prostatectomy experts
  • Renal Cell Carcinoma (RCC)
    Dr. Allaf is
    Elite
    . Learn about Renal Cell Carcinoma (RCC).
    See more Renal Cell Carcinoma (RCC) experts
  • Renal Oncocytoma
    Dr. Allaf is
    Elite
    . Learn about Renal Oncocytoma.
    See more Renal Oncocytoma experts
  • Distinguished
  • Familial Prostate Cancer
    Dr. Allaf is
    Distinguished
    . Learn about Familial Prostate Cancer.
    See more Familial Prostate Cancer experts
  • Testicular Cancer
    Dr. Allaf is
    Distinguished
    . Learn about Testicular Cancer.
    See more Testicular Cancer experts
  • Advanced
  • Chromophobe Renal Cell Carcinoma
    Dr. Allaf is
    Advanced
    . Learn about Chromophobe Renal Cell Carcinoma.
    See more Chromophobe Renal Cell Carcinoma experts
  • Clear Cell Sarcoma
    Dr. Allaf is
    Advanced
    . Learn about Clear Cell Sarcoma.
    See more Clear Cell Sarcoma experts
  • Empyema
    Dr. Allaf is
    Advanced
    . Learn about Empyema.
    See more Empyema experts
  • Familial Wilms Tumor 2
    Dr. Allaf is
    Advanced
    . Learn about Familial Wilms Tumor 2.
    See more Familial Wilms Tumor 2 experts
  • Orchiectomy
    Dr. Allaf is
    Advanced
    . Learn about Orchiectomy.
    See more Orchiectomy experts
  • Thrombectomy
    Dr. Allaf is
    Advanced
    . Learn about Thrombectomy.
    See more Thrombectomy experts
View All 10 Advanced Conditions
  • Experienced
  • Bladder Cancer
    Dr. Allaf is
    Experienced
    . Learn about Bladder Cancer.
    See more Bladder Cancer experts
  • Chylous Ascites
    Dr. Allaf is
    Experienced
    . Learn about Chylous Ascites.
    See more Chylous Ascites experts
  • Endoscopy
    Dr. Allaf is
    Experienced
    . Learn about Endoscopy.
    See more Endoscopy experts
  • Enlarged Prostate (BPH)
    Dr. Allaf is
    Experienced
    . Learn about Enlarged Prostate (BPH).
    See more Enlarged Prostate (BPH) experts
  • Erectile Dysfunction (ED)
    Dr. Allaf is
    Experienced
    . Learn about Erectile Dysfunction (ED).
    See more Erectile Dysfunction (ED) experts
  • Intussusception in Children
    Dr. Allaf is
    Experienced
    . Learn about Intussusception in Children.
    See more Intussusception in Children experts
View All 15 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.